NASDAQ:PRE Prenetics Global (PRE) Stock Price, News & Analysis $4.75 +0.16 (+3.49%) (As of 05:27 PM ET) Add Compare Share Share Today's Range$4.61▼$4.8050-Day Range$4.40▼$6.8052-Week Range$2.85▼$8.40Volume6,996 shsAverage Volume62,895 shsMarket Capitalization$43.40 millionP/E RatioN/ADividend YieldN/APrice Target$9.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Get Prenetics Global alerts: Email Address Prenetics Global MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside91.1% Upside$9.00 Price TargetShort InterestHealthy0.33% of Float Sold ShortDividend StrengthWeakBased on Four FactorsSustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.12 out of 5 starsMedical Sector731st out of 901 stocksAnalytical Instruments Industry21st out of 25 stocks 3.5 Analyst's Opinion Consensus RatingPrenetics Global has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoveragePrenetics Global has received no research coverage in the past 90 days.Read more about Prenetics Global's stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.33% of the float of Prenetics Global has been sold short.Short Interest Ratio / Days to CoverPrenetics Global has a short interest ratio ("days to cover") of 1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Prenetics Global has recently increased by 8.27%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldPrenetics Global does not currently pay a dividend.Dividend GrowthPrenetics Global does not have a long track record of dividend growth.Read more about Prenetics Global's dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for PRE. Previous Next 0.6 News and Social Media Coverage Search Interest5 people have searched for PRE on MarketBeat in the last 30 days. MarketBeat FollowsOnly 2 people have added Prenetics Global to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Prenetics Global insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 7.80% of the stock of Prenetics Global is held by insiders.Percentage Held by InstitutionsOnly 25.01% of the stock of Prenetics Global is held by institutions.Read more about Prenetics Global's insider trading history. Previous Next 0.6 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Prenetics Global is -1.06, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Prenetics Global is -1.06, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioPrenetics Global has a P/B Ratio of 0.20. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Prenetics Global's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Behind the MarketsHow you could collect “AI Royalties” from NVIDIA, META and TSMC...If you've missed out on the first wave of big AI winners... Don't worry. Because there's a much better - and potentially much more lucrative way - to play the $5 Trillion AI boom.Click here for the ticker >>> About Prenetics Global Stock (NASDAQ:PRE)Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies. In addition, the company, through its equity interests in ACT Genomics Holdings Company Limited, is involved in genomic profiling of solid tumors through ACTOnco. Prenetics Global Limited was founded in 2007 and is based in Quarry Bay, Hong Kong.Read More PRE Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PRE Stock News HeadlinesSeptember 2, 2024 | americanbankingnews.comContrasting Nautilus Biotechnology (NASDAQ:NAUT) & Prenetics Global (NASDAQ:PRE)August 19, 2024 | globenewswire.comPrenetics Announces Acquisition of Europa Sports Partners in Strategic Expansion to Consumer Health and Wellness IndustrySeptember 11, 2024 | Behind the Markets (Ad)ONE AI Stock is All You Need...If you want the potential for huge gains with AI stocks... You need to ignore 99% of the stock market.July 11, 2024 | globenewswire.comPrenetics, NASDAQ Health Sciences Company, Partners with David BeckhamJuly 1, 2024 | globenewswire.comPrenetics Welcomes Kathyrn M. Henry and David Vanderveen to Board of DirectorsJune 18, 2024 | investorplace.comPRE Stock Earnings: Prenetics Global Reported Results for Q1 2024April 6, 2024 | benzinga.comPrenetics Global Stock (NASDAQ:PRE), Analyst Ratings, Price Targets, PredictionsApril 3, 2024 | baystreet.caPrenetics Flat on Financial ResultsSeptember 11, 2024 | Behind the Markets (Ad)ONE AI Stock is All You Need...If you want the potential for huge gains with AI stocks... You need to ignore 99% of the stock market.April 1, 2024 | finanznachrichten.dePrenetics Global Limited: Prenetics Announces Fourth Quarter and Full Year 2023 Financial ResultsApril 1, 2024 | benzinga.comPrenetics Global: Q4 Earnings InsightsApril 1, 2024 | investorplace.comPRE Stock Earnings: Prenetics Global Beats EPS, Misses Revenue for Q4 2023April 1, 2024 | globenewswire.comPrenetics Announces Fourth Quarter and Full Year 2023 Financial ResultsFebruary 9, 2024 | finance.yahoo.comPrenetics Announces MOU for a Strategic Investment and 5-Year Research Collaboration with Metavisionaries to Pioneer R&D on the International Space StationFebruary 9, 2024 | globenewswire.comPrenetics Announces MOU for a Strategic Investment and 5-Year Research Collaboration with Metavisionaries to Pioneer R&D on the International Space StationJanuary 17, 2024 | msn.comPrenetics Global files to sell 1.48M Class A shares for holdersDecember 18, 2023 | investing.comPrenetics Global (PRE) Earnings Dates & ReportsDecember 17, 2023 | seekingalpha.comPRENW Prenetics Global Limited WT EXP 051827See More Headlines Receive PRE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Prenetics Global and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings6/18/2024Today9/11/2024Next Earnings (Estimated)9/20/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Analytical instruments Sub-IndustryMeasuring And Control Equipment Current SymbolNASDAQ:PRE CUSIPN/A CIK1876431 Webwww.prenetics.com Phone852-2210-9588FaxN/AEmployees1Year FoundedN/APrice Target and Rating Average Stock Price Target$9.00 High Stock Price Target$9.00 Low Stock Price Target$9.00 Potential Upside/Downside+91.1%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($4.45) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-62,720,000.00 Net Margins-282.96% Pretax Margin-232.96% Return on Equity-10.76% Return on Assets-8.79% Debt Debt-to-Equity RatioN/A Current Ratio2.33 Quick Ratio2.25 Sales & Book Value Annual Sales$23.23 million Price / Sales1.85 Cash FlowN/A Price / Cash FlowN/A Book Value$23.00 per share Price / Book0.20Miscellaneous Outstanding Shares9,137,000Free Float8,424,000Market Cap$43.04 million OptionableNot Optionable Beta-0.15 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesMr. Sheng Wu Yeung (Age 45)Co-Founder, Chairperson & CEO Dr. Chi Hung Tzang Ph.D. (Age 49)Co-Founder, Chief Scientific Officer & Member of Scientific Advisory Board Mr. Hoi Chun Lo (Age 39)Chief Financial Officer Dr. Yung Ho Wong DPHIL (Age 42)Chief Technology Officer Ms. Samantha KwokChief of Staff to Group CEO & Vice President, People & OperationsDr. Senthil Sundaram M.D. (Age 50)Chief Clinical Officer Mr. Joel Neoh (Age 40)Chief Consumer Officer & Chief Executive Officer for CircleDNA Mr. Walt LingChief Executive Officer of ACT GenomicsMore ExecutivesKey CompetitorsQuantum-SiNASDAQ:QSIFrequency ElectronicsNASDAQ:FEIM908 DevicesNASDAQ:MASSKewaunee ScientificNASDAQ:KEQUAkoya BiosciencesNASDAQ:AKYAView All CompetitorsInstitutional OwnershipPrudential PLCSold 201,859 shares on 8/7/2024Ownership: 5.286%View All Institutional Transactions PRE Stock Analysis - Frequently Asked Questions How have PRE shares performed this year? Prenetics Global's stock was trading at $5.91 at the beginning of the year. Since then, PRE shares have decreased by 20.3% and is now trading at $4.71. View the best growth stocks for 2024 here. How were Prenetics Global's earnings last quarter? Prenetics Global Limited (NASDAQ:PRE) issued its quarterly earnings results on Tuesday, June, 18th. The company reported ($0.38) earnings per share for the quarter. The company earned $6.41 million during the quarter. Prenetics Global had a negative net margin of 282.96% and a negative trailing twelve-month return on equity of 10.76%. When did Prenetics Global's stock split? Prenetics Global shares reverse split on Tuesday, November 14th 2023. The 1-15 reverse split was announced on Wednesday, November 1st 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, November 13th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split. Who are Prenetics Global's major shareholders? Top institutional shareholders of Prenetics Global include Prudential PLC (5.29%). How do I buy shares of Prenetics Global? Shares of PRE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:PRE) was last updated on 9/11/2024 by MarketBeat.com Staff From Our PartnersPreferred Stock Offer: Get an 8% dividend yield opportunity on this robotics stockThis company, known for its autonomous robotic surgical systems, completed a crowd-funded public offering and ...Deal Maker | SponsoredThe #1 Altcoin for September 2024With thousands of cryptocurrencies out there, it's crucial to focus on the ONE that has the potential to make ...Crypto 101 Media | SponsoredPlace this $0.99 trade BEFORE the electionEarlier this year, Millionaire Trader Nate Bear of Monument Traders Alliance went live in front of thousands o...Monument Traders Alliance | SponsoredNatural is heading to the NasdaqNatural solutions are already better for the environment. But there’s one company taking it a step further: Th...MedX | SponsoredHow to grow a small trading account into a $100k? Why is Warren Buffett dumping stocks? Billionaires like Warren Buffett, Tim Cook, and Jeff Bezos are offloa...Timothy Sykes | SponsoredWarning For Nvidia HoldersHow The Boeing Disasters Could Hit Nvidia Investors You may have heard about Boeing planes falling apart mi...Stansberry Research | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Prenetics Global Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Prenetics Global With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
